{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:18:38Z","timestamp":1788221918123,"version":"build-2803163510"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.neubiorev.2023.105298","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:47:38Z","timestamp":1687956458000},"page":"105298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses"],"prefix":"10.1016","volume":"152","author":[{"given":"Chiara","family":"Possidente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2023.105298_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jad.2018.11.090","article-title":"Double-blind, placebo-controlled trial of pioglitazone for bipolar depression","volume":"245","author":"Aftab","year":"2019","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/dc09-0071","article-title":"Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes","volume":"32","author":"Aikens","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/appi.ajp.2008.08071065","article-title":"Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus","volume":"166","author":"Andersohn","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes: a meta-analysis","volume":"24","author":"Anderson","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-016-0985-7","article-title":"The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism","volume":"14","author":"Andreozzi","year":"2016","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/gps.2409","article-title":"Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA)","volume":"25","author":"Atlantis","year":"2010","journal-title":"Int J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0165-0327(12)70006-X","article-title":"Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA)","volume":"142","author":"Atlantis","year":"2012","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2013.02.019","article-title":"Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study","volume":"150","author":"Bai","year":"2013","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib9","first-page":"CD008381","article-title":"Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression","volume":"12","author":"Baumeister","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2023.105298_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000517953","article-title":"Prodromal symptoms in depression: a systematic review","volume":"90","author":"Benasi","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.neubiorev.2023.105298_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2023.105298_bib12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00125-021-05393-8","article-title":"Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study","volume":"64","author":"Biessels","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2023.105298_bib13","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.2337\/diacare.26.10.2822","article-title":"Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes","volume":"26","author":"Black","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2018.01.004","article-title":"Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies","volume":"83","author":"Burghardt","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib16","first-page":"83","article-title":"Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD Study): a randomized, quadruple-masked, placebo-controlled clinical trial","author":"Calkin","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41398-022-02122-6","article-title":"Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder","volume":"12","author":"Campbell","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/aje\/kwg172","article-title":"Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992","volume":"158","author":"Carnethon","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1399-5618.2007.00534.x","article-title":"Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients","volume":"9","author":"Castilla-Puentes","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2016.12.006","article-title":"A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder","volume":"210","author":"Cha","year":"2017","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109872","article-title":"The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: relevance for bipolar disorder","volume":"99","author":"Chaves Filho","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/dc12-0473","article-title":"Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression","volume":"36","author":"Chen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib23","article-title":"Diabetes increases the risk of depression: a systematic review, meta-analysis and estimates of population attributable fractions based on prospective studies","volume":"14","author":"Chireh","year":"2019","journal-title":"Prev. Med Rep."},{"key":"10.1016\/j.neubiorev.2023.105298_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajmg.b.32478","article-title":"Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort","volume":"174","author":"Clarke","year":"2017","journal-title":"Am. J. Med Genet B Neuropsychiatr. Genet"},{"key":"10.1016\/j.neubiorev.2023.105298_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDT.S121149","article-title":"Pioglitazone could induce remission in major depression: a meta-analysis","volume":"13","author":"Colle","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neubiorev.2023.105298_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib27","unstructured":"Dattani, S., Ritchie, H. & Roser, M. 2021. Mental Health. Our World in Data. \u3008https:\/\/ourworldindata.org\/mental-health\u3009."},{"key":"10.1016\/j.neubiorev.2023.105298_bib28","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2023.105298_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2190\/PM.48.4.c","article-title":"Depressive symptoms and type 2 diabetes mellitus in rural appalachia: an 18-month follow-up study","volume":"48","author":"De Groot","year":"2015","journal-title":"Int J. Psychiatry Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/dc18-2400","article-title":"Program ACTIVE II: outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes","volume":"42","author":"De Groot","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/PSY.0000000000000169","article-title":"Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus","volume":"77","author":"Demmer","year":"2015","journal-title":"Psychosom. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpsychores.2016.08.011","article-title":"Prediabetes, depressive and anxiety symptoms, and risk of type 2 diabetes: a community-based cohort study","volume":"89","author":"Deschenes","year":"2016","journal-title":"J. Psychosom. Res"},{"key":"10.1016\/j.neubiorev.2023.105298_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12971","article-title":"An association between YKL-40 and type 2 diabetes in psychotic disorders","volume":"139","author":"Dieset","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2023.105298_bib34","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1464-5491.2012.03687.x","article-title":"An analysis of the relative risk for hypothyroidism in patients with Type 2 diabetes","volume":"29","author":"Diez","year":"2012","journal-title":"Diabet. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib35","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2337\/dc09-0785","article-title":"Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Echeverry","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psym.2011.12.009","article-title":"Depressive symptom deterioration among predominantly Hispanic diabetes patients in safety net care","volume":"53","author":"Ell","year":"2012","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neubiorev.2023.105298_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychores.2006.07.009","article-title":"The role of depression and anxiety in onset of diabetes in a large population-based study","volume":"62","author":"Engum","year":"2007","journal-title":"J. Psychosom. Res"},{"key":"10.1016\/j.neubiorev.2023.105298_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.04.011","article-title":"Depression, antidepressants, and insulin resistance: which link?","volume":"60","author":"Fanelli","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib39","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.euroneuro.2022.07.214","article-title":"Local patterns of shared genetics and a genetic latent factor of insulin resistance and neuropsychiatric multimorbidity","volume":"63","author":"Fanelli","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib40","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1038\/s41398-022-01817-0","article-title":"Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders","volume":"12","author":"Fanelli","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104927","article-title":"The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review","volume":"143","author":"Fanelli","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neubiorev.2023.105298_bib42","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1464-5491.2008.02533.x","article-title":"A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes","volume":"25","author":"Fisher","year":"2008","journal-title":"Diabet. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/157339907782330021","article-title":"A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus","volume":"3","author":"Golden","year":"2007","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.neubiorev.2023.105298_bib44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/diacare.27.2.429","article-title":"Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study","volume":"27","author":"Golden","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib45","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.299.23.2751","article-title":"Examining a bidirectional association between depressive symptoms and diabetes","volume":"299","author":"Golden","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2023.105298_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","article-title":"Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms","volume":"25","author":"Goncalves","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard","year":"2011","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arcmed.2004.12.018","article-title":"Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients","volume":"36","author":"Gulseren","year":"2005","journal-title":"Arch. Med Res."},{"key":"10.1016\/j.neubiorev.2023.105298_bib49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"Suppl 2","key":"10.1016\/j.neubiorev.2023.105298_bib50","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1002\/dmrr.249","article-title":"The mode of action of thiazolidinediones","volume":"18","author":"Hauner","year":"2002","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.neubiorev.2023.105298_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002058","article-title":"Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study","volume":"13","author":"Hayes","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jdiacomp.2003.11.001","article-title":"A randomised trial of insulin on well-being and carer strain in elderly type 2 diabetic subjects","volume":"18","author":"Hendra","year":"2004","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.neubiorev.2023.105298_bib53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2023.105298_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrendo.2014.203","article-title":"Diabetes mellitus and severe mental illness: mechanisms and clinical implications","volume":"11","author":"Holt","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib55","first-page":"14","article-title":"Diabetes and depression","author":"Holt","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.neubiorev.2023.105298_bib56","first-page":"83","article-title":"Mortality and suicide related to major depressive disorder before and after type 2 diabetes mellitus","author":"Huang","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s11136-015-1165-6","article-title":"Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial","volume":"25","author":"Huang","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.neubiorev.2023.105298_bib58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jad.2016.07.011","article-title":"Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: systematic review and meta-analysis","volume":"206","author":"Hunt","year":"2016","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib59","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00125-017-4367-3","article-title":"The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study","volume":"60","author":"Ismail","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2023.105298_bib60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jdiacomp.2015.12.013","article-title":"Prevalence of depression in type 2 diabetes patients in German primary care practices","volume":"30","author":"Jacob","year":"2016","journal-title":"J. Diabetes Complicat."},{"issue":"None","key":"10.1016\/j.neubiorev.2023.105298_bib61","article-title":"Prevalence and characteristics of antidepressant prescribing in adults with comorbid depression and type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"1","author":"Jeffery","year":"2021","journal-title":"Health Sci. Rev. (Oxf. )"},{"key":"10.1016\/j.neubiorev.2023.105298_bib62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.mp.4000696","article-title":"Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium","volume":"5","author":"Johnston-Wilson","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000022163","article-title":"Is depression a risk factor for dementia or cognitive decline? A review","volume":"46","author":"Jorm","year":"2000","journal-title":"Gerontology"},{"key":"10.1016\/j.neubiorev.2023.105298_bib64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4093\/dmj.2020.0008","article-title":"Increased risk of cardiovascular disease and mortality in patients with diabetes and coexisting depression: a nationwide population-based cohort study","volume":"45","author":"Jung","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.neubiorev.2023.105298_bib65","first-page":"1307","article-title":"Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial","volume":"11","author":"Kang","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neubiorev.2023.105298_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ijcp.12112","article-title":"Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus","volume":"67","author":"Karaiskos","year":"2013","journal-title":"Int J. Clin. Pr."},{"key":"10.1016\/j.neubiorev.2023.105298_bib67","unstructured":"Kasina, S. & Baradhi, K.M. 2022. Dipeptidyl Peptidase IV (DPP IV) Inhibitors. StatPearls. Treasure Island (FL)."},{"key":"10.1016\/j.neubiorev.2023.105298_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105298_bib69","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jad.2011.06.033","article-title":"Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity","volume":"136","author":"Kemp","year":"2012","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40263-014-0158-2","article-title":"PPAR-gamma agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression","volume":"28","author":"Kemp","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2023.105298_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes \u2013 global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.neubiorev.2023.105298_bib72","first-page":"42","article-title":"Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?","volume":"16","author":"Khazaie","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2023.105298_bib73","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2337\/dc10-1187","article-title":"Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study","volume":"33","author":"Kivimaki","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib74","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.biopsych.2011.07.008","article-title":"Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?","volume":"70","author":"Kivimaki","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib75","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00125-006-0159-x","article-title":"Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis","volume":"49","author":"Knol","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2023.105298_bib76","article-title":"Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes","author":"Kohler-Forsberg","year":"2022","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib77","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1007\/s43032-021-00765-2","article-title":"PCOS and depression: common links and potential targets","volume":"29","author":"Kolhe","year":"2022","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.neubiorev.2023.105298_bib78","first-page":"27","article-title":"Hypoglycemic agents and potential anti-inflammatory activity","volume":"9","author":"Kothari","year":"2016","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.neubiorev.2023.105298_bib79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2021.12.047","article-title":"Cardiometabolic risk markers during mood-stabilizing treatment: correlation with drug-specific effects, depressive symptoms and treatment response","volume":"300","author":"Kuperberg","year":"2022","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib80","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"Labuzek","year":"2010","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.neubiorev.2023.105298_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.diabres.2017.01.006","article-title":"Social relations, depressive symptoms, and incident type 2 diabetes mellitus: the English Longitudinal Study of Ageing","volume":"126","author":"Laursen","year":"2017","journal-title":"Diabetes Res Clin. Pr."},{"issue":"Suppl 1","key":"10.1016\/j.neubiorev.2023.105298_bib82","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","article-title":"The role of GSK3 in glucose homeostasis and the development of insulin resistance","volume":"77","author":"Lee","year":"2007","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.neubiorev.2023.105298_bib83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/dc09-1068","article-title":"Depression and advanced complications of diabetes: a prospective cohort study","volume":"33","author":"Lin","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib84","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796020000438","article-title":"Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study","volume":"29","author":"Lloyd","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.neubiorev.2023.105298_bib85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00006842-199705000-00007","article-title":"Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial","volume":"59","author":"Lustman","year":"1997","journal-title":"Psychosom. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-129-8-199810150-00005","article-title":"Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial","volume":"129","author":"Lustman","year":"1998","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib87","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/diacare.23.5.618","article-title":"Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial","volume":"23","author":"Lustman","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib88","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/dc06-1769","article-title":"Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion","volume":"30","author":"Lustman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fpsyt.2019.00057","article-title":"Insulin resistance as a shared pathogenic mechanism between depression and type 2 diabetes","volume":"10","author":"Lyra","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib90","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/dc11-1223","article-title":"Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women","volume":"34","author":"Ma","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.euroneuro.2021.04.021","article-title":"Bidirectional associations between treatment-resistant depression and general medical conditions","volume":"51","author":"Madsen","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib93","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpsychires.2020.12.007","article-title":"Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin","volume":"133","author":"Mansur","year":"2021","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.neubiorev.2023.105298_bib94","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archinte.167.11.1137","article-title":"Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study","volume":"167","author":"Maraldi","year":"2007","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib95","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bdi.12006","article-title":"A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder","volume":"14","author":"Mcintyre","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2018.02.052","article-title":"Association between major depressive episode and risk of type 2 diabetes: a large prospective cohort study in Chinese adults","volume":"234","author":"Meng","year":"2018","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib97","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis","volume":"31","author":"Mezuk","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib98","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","article-title":"Depression heterogeneity and its biological underpinnings: toward immunometabolic depression","volume":"88","author":"Milaneschi","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib99","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0165-0327(12)70008-3","article-title":"Economic aspects of the association between diabetes and depression: a systematic review","volume":"142","author":"Molosankwe","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psyneuen.2018.05.010","article-title":"Repositioning of diabetes treatments for depressive symptoms: a systematic review and meta-analysis of clinical trials","volume":"94","author":"Moulton","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2023.105298_bib101","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/PSY.0000000000000985","article-title":"SITagliptin for depressive symptoms in type 2 diabetes: a feasibility randomized controlled trial","volume":"83","author":"Moulton","year":"2021","journal-title":"Psychosom. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2018.09.017","article-title":"Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain","volume":"143","author":"Mueller","year":"2018","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.neubiorev.2023.105298_bib103","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2337\/dc16-2018","article-title":"Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk","volume":"40","author":"Naicker","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib104","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neubiorev.2018.05.014","article-title":"A review of brain insulin signaling in mood disorders: From biomarker to clinical target","volume":"92","author":"Nguyen","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2023.105298_bib105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jad.2022.04.156","article-title":"Investigating the pro-cognitive and anti-depressant efficacy of metformin: a systematic review and meta-analysis of randomised controlled trials","volume":"310","author":"Nibber","year":"2022","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib106","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.diabres.2013.05.009","article-title":"Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control","volume":"101","author":"Nicolau","year":"2013","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.neubiorev.2023.105298_bib107","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2337\/dc16-0048","article-title":"Increased risk of incident chronic kidney disease, cardiovascular disease, and mortality in patients with diabetes with comorbid depression","volume":"39","author":"Novak","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14767","article-title":"Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany","volume":"39","author":"Nubel","year":"2022","journal-title":"Diabet. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib109","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neubiorev.2023.105298_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2296-4-7","article-title":"Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial","volume":"4","author":"Paile-Hyvarinen","year":"2003","journal-title":"BMC Fam. Pr."},{"key":"10.1016\/j.neubiorev.2023.105298_bib111","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2296-8-34","article-title":"Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial","volume":"8","author":"Paile-Hyvarinen","year":"2007","journal-title":"BMC Fam. Pr."},{"key":"10.1016\/j.neubiorev.2023.105298_bib112","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/archinternmed.2010.356","article-title":"Bidirectional association between depression and type 2 diabetes mellitus in women","volume":"170","author":"Pan","year":"2010","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00125-011-2268-4","article-title":"Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults","volume":"55","author":"Pan","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2023.105298_bib114","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.genhosppsych.2016.08.007","article-title":"Three-year mortality in relation to early hospitalization and number of outpatient clinic visits in people with newly diagnosed bipolar disorder","volume":"43","author":"Pan","year":"2016","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1745-6215-10-78","article-title":"Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial","volume":"10","author":"Pibernik-Okanovic","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.neubiorev.2023.105298_bib116","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13063-015-0833-8","article-title":"Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual","volume":"16","author":"Pibernik-Okanovic","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.neubiorev.2023.105298_bib117","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/MLR.0b013e318215d0c9","article-title":"A randomized trial of telephonic counseling plus walking for depressed diabetes patients","volume":"49","author":"Piette","year":"2011","journal-title":"Med Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib118","author":"Pozzi","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neubiorev.2023.105298_bib119","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00125-022-05723-4","article-title":"Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study","author":"Prigge","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2023.105298_bib120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1100\/tsw.2010.32","article-title":"Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study","author":"Rasgon","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neubiorev.2023.105298_bib121","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Raymond","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.neubiorev.2023.105298_bib122","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8227(01)00327-8","article-title":"Insulin improves well-being for selected elderly type 2 diabetic subjects","volume":"55","author":"Reza","year":"2002","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.neubiorev.2023.105298_bib123","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/diab.38.5.648","article-title":"Normalization of insulin sensitivity with lithium in diabetic rats","volume":"38","author":"Rossetti","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.neubiorev.2023.105298_bib124","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.12r07922","article-title":"Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies","volume":"74","author":"Rotella","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib125","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/dc10-1033","article-title":"Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study","volume":"33","author":"Rubin","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib126","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc13-0816","article-title":"A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes","volume":"37","author":"Safren","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020768","article-title":"Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study): results from the MADIABETES cohort","volume":"8","author":"Salinero-Fort","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.neubiorev.2023.105298_bib128","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc11-0031","article-title":"Increased risk of myocardial infarction in depressed patients with type 2 diabetes","volume":"34","author":"Scherrer","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amjmed.2010.11.015","article-title":"Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients","volume":"124","author":"Scherrer","year":"2011","journal-title":"Am. J. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychores.2012.09.021","article-title":"The pattern of depressive symptoms in people with type 2 diabetes: a prospective community study","volume":"74","author":"Schmitz","year":"2013","journal-title":"J. Psychosom. Res"},{"key":"10.1016\/j.neubiorev.2023.105298_bib131","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/mp.2016.7","article-title":"Depression and risk of type 2 diabetes: the potential role of metabolic factors","volume":"21","author":"Schmitz","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib132","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.beth.2015.10.005","article-title":"Feasibility of pairing behavioral activation with exercise for women with type 2 diabetes and depression: the get it study pilot randomized controlled trial","volume":"47","author":"Schneider","year":"2016","journal-title":"Behav. Ther."},{"key":"10.1016\/j.neubiorev.2023.105298_bib133","first-page":"10","article-title":"The geriatric depression scale predicts glycemic control in older adult with type 2 diabetes mellitus: a longitudinal study","author":"Sirirak","year":"2022","journal-title":"Healthcare"},{"key":"10.1016\/j.neubiorev.2023.105298_bib134","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/bjp.bp.110.083840","article-title":"Unrecognised bipolar disorder in primary care patients with depression","volume":"199","author":"Smith","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00406-018-0923-1","article-title":"12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany","volume":"269","author":"Speerforck","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105298_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104731","article-title":"Antidepressants for depressed patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of short-term randomized controlled trials","volume":"139","author":"Srisurapanont","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neubiorev.2023.105298_bib137","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.npbr.2015.07.002","article-title":"Role of physical activity and diet on mood, behavior, and cognition","volume":"21","author":"Strasser","year":"2015","journal-title":"Neurol., Psychiatry Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105298_bib138","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.2337\/dc11-1791","article-title":"Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy","volume":"35","author":"Sullivan","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib139","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2013.03.036","article-title":"Metformin induces up-regulation of blood-brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells","volume":"433","author":"Takata","year":"2013","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.neubiorev.2023.105298_bib140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00125-020-05131-6","article-title":"Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study","volume":"63","author":"Tang","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2023.105298_bib141","article-title":"Psychiatric disorders and Type 2 diabetes mellitus: A bidirectional Mendelian randomization","author":"Tao","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.neubiorev.2023.105298_bib142","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/18715303113139990037","article-title":"Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes","volume":"13","author":"Tasci","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.neubiorev.2023.105298_bib143","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00592-015-0806-0","article-title":"Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study","volume":"52","author":"Trento","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib144","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/02813432.2019.1639904","article-title":"The profiles of health care utilization among a non-depressed population and patients with depressive symptoms with and without clinical depression","volume":"37","author":"Tusa","year":"2019","journal-title":"Scand. J. Prim. Health Care"},{"key":"10.1016\/j.neubiorev.2023.105298_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1981","article-title":"Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: systematic review and meta-analysis","volume":"11","author":"Van Der Feltz-Cornelis","year":"2021","journal-title":"Brain Behav."},{"issue":"166\u201374","key":"10.1016\/j.neubiorev.2023.105298_bib146","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib147","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20614","article-title":"The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Vancampfort","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib148","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000118351","article-title":"Does long-term lithium treatment induce diabetes mellitus?","volume":"17","author":"Vestergaard","year":"1987","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neubiorev.2023.105298_bib149","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2023.105298_bib150","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2023.105298_bib151","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1741-7015-10-150","article-title":"Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study","volume":"10","author":"Wahlqvist","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib152","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12888-019-2305-2","article-title":"Socio-demographic characteristics and co-occurrence of depressive symptoms with chronic diseases among older adults in China: the China longitudinal ageing social survey","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib153","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/dme.13372","article-title":"Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5-year depression trajectories using latent class growth analysis","volume":"34","author":"Whitworth","year":"2017","journal-title":"Diabet. Med"},{"key":"10.1016\/j.neubiorev.2023.105298_bib154","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12888-022-04163-z","article-title":"Temporally ordered associations between type 2 diabetes and brain disorders - a Danish register-based cohort study","volume":"22","author":"Wimberley","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105298_bib155","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jad.2013.05.008","article-title":"Recurrent depression, cardiovascular disease, and diabetes among middle-aged and older adult women","volume":"150","author":"Windle","year":"2013","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib156","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jad.2021.05.103","article-title":"An analysis of the relative and absolute incidence of somatic morbidity in patients with affective disorders-a nationwide cohort study","volume":"292","author":"Wium-Andersen","year":"2021","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2023.105298_bib157","unstructured":"World Health Organization. 2022. Diabetes, Fact Sheets [Online]. Geneva. Available: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes\u3009 [Accessed]."},{"key":"10.1016\/j.neubiorev.2023.105298_bib158","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s11684-018-0671-7","article-title":"Type 2 diabetes is causally associated with depression: a Mendelian randomization analysis","volume":"12","author":"Xuan","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.neubiorev.2023.105298_bib159","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/aje\/kwi089","article-title":"Depressive symptoms and mortality among persons with and without diabetes","volume":"161","author":"Zhang","year":"2005","journal-title":"Am. J. Epidemiol."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423002671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423002671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:41:36Z","timestamp":1758969696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763423002671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":159,"alternative-id":["S0149763423002671"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105298","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105298"}}